UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 4, 2015

 

OncoSec Medical Incorporated

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-54318

 

98-0573252

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

5820 Nancy Ridge Drive
San Diego, CA

 

92121

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (855) 662-6732

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o          Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o          Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o          Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o          Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07                                           Submission of Matters to a Vote of Security Holders.

 

On December 4, 2015, OncoSec Medical Incorporated (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”) at the Company’s headquarters located at 5820 Nancy Ridge Drive, San Diego, California 92121.

 

The final voting results on the matters presented at the Annual Meeting were as follows:

 

Proposal 1—To elect four directors to the Company’s Board of Directors to serve for a term of one year or until successors are duly elected and qualified.

 

Directors

 

For

 

Withheld

 

Broker Non-Votes

Dr. Avtar Dhillon

 

1,964,314

 

667,048

 

7,343,173

Dr. Anthony Maida

 

2,112,445

 

518,917

 

7,343,173

Dr. James DeMesa

 

2,060,661

 

570,701

 

7,343,173

Punit Dhillon

 

1,970,830

 

660,532

 

7,343,173

 

Proposal 2—To approve the Company’s 2015 Employee Stock Purchase Plan.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

2,271,215

 

316,120

 

44,027

 

7,343,173

 

Proposal 3—To ratify the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for the fiscal year ending July 31, 2016.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

9,718,185

 

189,332

 

67,018

 

 

Proposal 4—To approve, on an advisory basis, the compensation of the Company’s named executive officers.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

2,153,487

 

413,942

 

63,933

 

7,343,173

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 7, 2015

 

OncoSec Medical Incorporated

 

 

 

 

By:

/s/ Punit Dhillon

 

 

Name:

Punit Dhillon

 

 

Title:

President and Chief Executive Officer

 

1